LIDDS: Towards phase III in China
Research Note
2019-11-07
10:43
LPC-004 is on the move towards phase III in China as LIDDS partner,Jiangxi Puheng Pharma, initiated contacts with the Chinese medical authority.
JS
Jakob Svensson
Disclosures and disclaimers